News

Under the deal, Allergan investors would receive $129.22 in cash and 0.3683 Actavis shares for each share of the Botox-maker’s common stock. The combination will create one of

Both the firms will explore the therapeutic potential of this new anti-PD-L1 antibody as a single agent as well as in various combinations with their broad portfolio of

As part of this deal, all of Roche’s rights to INO-5150, including the right to license the product to other parties, will be returned to Inovio, which now

The project will focus on non-valvular atrial fibrillation (NVAF) and will examine disease prevalence, treatment complications, such as hospital readmissions, as well as the use of evidence-based guidelines.

The randomized double blind trial included a total of 418 patients with treatment naïve BRAF wild-type unresectable Stage III and IV melanoma and they were given either Opdivo

A total of 239 subjects infected with HPV 16 and/or 18 were enrolled at 39 clinical sites across seven European countries including Belgium, Finland, France, Germany, the Netherlands,

The FDA approval is based on results from the Phase III AURELIA trial that showed Avastin plus chemotherapy reduced the risk of disease worsening or death (progression-free survival)

These results will be presented in a poster presentation this evening at 7:30 PM ET at the 19th Annual Scientific Meeting and Education Day of the Society for

Initial results are being presented this weekend to clinicians convening during the American Heart Association meeting held in Chicago, including a meeting of the Association of Black Cardiologists.